1. Home
  2. ATAI vs HDL Comparison

ATAI vs HDL Comparison

Compare ATAI & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • HDL
  • Stock Information
  • Founded
  • ATAI 2018
  • HDL 2016
  • Country
  • ATAI Netherlands
  • HDL Singapore
  • Employees
  • ATAI N/A
  • HDL N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • HDL Restaurants
  • Sector
  • ATAI Health Care
  • HDL Consumer Discretionary
  • Exchange
  • ATAI Nasdaq
  • HDL Nasdaq
  • Market Cap
  • ATAI 1.1B
  • HDL 1.1B
  • IPO Year
  • ATAI 2021
  • HDL 2024
  • Fundamental
  • Price
  • ATAI $5.84
  • HDL $17.43
  • Analyst Decision
  • ATAI Strong Buy
  • HDL
  • Analyst Count
  • ATAI 5
  • HDL 0
  • Target Price
  • ATAI $14.00
  • HDL N/A
  • AVG Volume (30 Days)
  • ATAI 7.0M
  • HDL 1.2K
  • Earning Date
  • ATAI 11-14-2025
  • HDL 11-24-2025
  • Dividend Yield
  • ATAI N/A
  • HDL N/A
  • EPS Growth
  • ATAI N/A
  • HDL 197.81
  • EPS
  • ATAI N/A
  • HDL 0.09
  • Revenue
  • ATAI $2,309,000.00
  • HDL $805,433,000.00
  • Revenue This Year
  • ATAI $736.04
  • HDL $11.57
  • Revenue Next Year
  • ATAI N/A
  • HDL $12.00
  • P/E Ratio
  • ATAI N/A
  • HDL $20.71
  • Revenue Growth
  • ATAI 510.85
  • HDL 9.65
  • 52 Week Low
  • ATAI $1.04
  • HDL $15.54
  • 52 Week High
  • ATAI $6.75
  • HDL $30.00
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 54.11
  • HDL 38.44
  • Support Level
  • ATAI $5.50
  • HDL $17.51
  • Resistance Level
  • ATAI $6.23
  • HDL $17.66
  • Average True Range (ATR)
  • ATAI 0.47
  • HDL 0.26
  • MACD
  • ATAI -0.05
  • HDL -0.02
  • Stochastic Oscillator
  • ATAI 36.10
  • HDL 34.93

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.

Share on Social Networks: